# OREIOS International Study

> **NCT05239507** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1127 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05239507
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-01
- **Primary completion:** 2023-03-12
- **Final completion:** 2023-03-12
- **Target enrollment:** 1127 (ACTUAL)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05239507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05239507, "OREIOS International Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05239507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*